Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Samsung Biologics Co.,Ltd.
  6. Company
    A207940   KR7207940008

SAMSUNG BIOLOGICS CO.,LTD.

(A207940)
  Report
End-of-day quote. End-of-day quote Korea Stock Exchange - 01/27
712000 KRW   -5.94%
01/25Samsung Biologics' Q4 Net Profit Slumps, Revenue Jumps
MT
01/18S.Korea stocks hit 7-week closing low ahead of LGES IPO
RE
01/18SAMSUNG BIOLOGICS : Prior Notice on Disclosure of Final Earnings
PU
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Samsung Biologics Co Ltd is a Korea-based company primarily engaged in development, manufacture and distribution of biological products. The Company, as a contract manufacturing organization (CMO), mainly develops and manufactures antibody drugs used for treatment of cancer, autoimmune disease, diabetes and chronic diseases. It also provides cell line development and process development services. The Company distributes its products in domestic and overseas markets.

Number of employees : 2 886 people.
Sales per Business
20192020Delta
Biological Drugs648 375.0092.4%1 102 590.0094.7% +70.05%
Other53 217.207.6%62 183.605.3% +16.85%
KRW in Million
Sales per region
20192020Delta
Europe418 234.0059.6%527 493.0045.3% +26.12%
South Korea207 120.0029.5%296 608.0025.5% +43.21%
United States62 384.408.9%289 478.0024.9% +364.02%
Other13 853.202%51 197.104.4% +269.57%
KRW in Million
Managers
Name Title Age Since
John Chongbo Rim President, Chief Executive Officer & Director 60 2020
Yong-Ho An Managing Director & Head-Process Technology 53 -
Hyung-Woo Moon Head-Compliance Support 51 2017
Seok-Woo Jung, Dr. Independent Director 59 -
Soon-Jo Kwon, Dr. Independent Director 56 -
Geun-Nyeong Heo Independent Director 65 2019
James Choi Managing Director & Head-Investor Relations 54 2014
Young Yang Eun Head-Sales 47 2020
Kyu-Sung Lee, Dr. Executive Vice President 61 -
Dong-Joong Kim Chief Financial Officer, Director & Senior VP 56 -
Members of the board
Name Title Age Since
Tae-Han Kim Chairman 64 -
Dong-Joong Kim Chief Financial Officer, Director & Senior VP 56 -
Seok-Woo Jung, Dr. Independent Director 59 -
Soon-Jo Kwon, Dr. Independent Director 56 -
Geun-Nyeong Heo Independent Director 65 2019
John Chongbo Rim President, Chief Executive Officer & Director 60 2020
Eunice Kim Director 62 -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 66,165,000 16,530,711 25.0% 0 0.0% 25.0%
Shareholders
NameEquities%
Samsung C&T Corporation 28,742,466 43.4%
Samsung Electronics Co., Ltd. 20,836,832 31.5%
National Pension Service of Korea 3,374,607 5.10%
Invesco Advisers, Inc. 1,097,768 1.66%
BlackRock Fund Advisors 374,952 0.57%
The Vanguard Group, Inc. 340,127 0.51%
Samsung Asset Management Co., Ltd. 324,750 0.49%
Norges Bank Investment Management 212,228 0.32%
Fidelity Management & Research Co. LLC 174,144 0.26%
Canada Pension Plan Investment Board 148,071 0.22%
Company contact information
SAMSUNG BIOLOGICS Co., Ltd.
300 Songdo Bio Way
Yeonsu-gu
Inchon, Incheon 21987

Phone : +82.32.455.3114
Fax : +82.32.455.3825
Web : http://www.samsungbiologics.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Samsung Biologics Co.,Ltd.
Connections : Samsung Biologics Co.,Ltd.